ReviewCurrent neurology and neuroscience reports2018
An Up to Date Review of Pseudotumor Cerebri Syndrome.
Review in Current neurology and neuroscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 79 citations in OpenAlex.
- Etiological workup of pseudotumor cerebri in pediatric patients-is it really necessary?European journal of pediatrics · 2025Article
- Fulminant Idiopathic Intracranial Hypertension-Clinical Characteristics and Continuous Drainage as a Novel Treatment Approach.European journal of neurology · 2025Article
- A Systematic Review of Sleep Disturbance in Idiopathic Intracranial Hypertension.Neurology. Clinical practice · 2025Review
- Tortuous occipital emissary vein combined with dural venous sinus stenosis in contrast-enhanced MRV for evaluation of idiopathic intracranial hypertension.Japanese journal of radiology · 2024Article
- Therapeutic effect of a single lumbar puncture in idiopathic intracranial hypertension.The journal of headache and pain · 2024Observational
- A genetic survey of patients with familial idiopathic intracranial hypertension residing in a Middle Eastern village: genetic association study.European journal of medical research · 2024Article
- Acute Promyelocytic Leukemia: Review of Complications Related to All-Trans Retinoic Acid and Arsenic Trioxide Therapy.Cancers · 2024Review
- Severe bilateral papilledema after sigmoid sinus constriction surgery: a case report.BMC ophthalmology · 2023Article
- Frontonasal Encephalocele Complicated With Pseudotumor Cerebri: A Case Report and Literature Review.Cureus · 2023Article
- How to understand an enlarged Meckel's cave? An anatomical study.Surgical and radiologic anatomy : SRA · 2023Article
- Article
- [Pseudotumor cerebri in children and adolescents at the Saarland University Medical Center: a retrospective study].Wiener medizinische Wochenschrift (1946) · 2023Article
- Tetracycline-, Doxycycline-, Minocycline-Induced Pseudotumor Cerebri and Esophageal Perforation.Advances in therapy · 2023Review
- Cerebrospinal Fluid Protein Concentrations in Hydrocephalus.Children (Basel, Switzerland) · 2023Article
- Pediatric obesity-Long-term consequences and effect of weight loss.Journal of internal medicine · 2022Review
- Optic ataxia in a patient with HaNDL syndrome.BMJ case reports · 2022Article
- Idiopathic Intracranial Hypertension from Benign to Fulminant: Diagnostic and Management Issues.Annals of Indian Academy of Neurology · 2022Article
- External cranial expansion as treatment of intracranial hypertension. Technical note.Neurosurgical review · 2022Article
- A New Perspective on the Pathophysiology of Idiopathic Intracranial Hypertension: Role of the Glia-Neuro-Vascular Interface.Frontiers in molecular neuroscience · 2022Article
- How do presentation age and CSF opening pressure level affect long-term prognosis of pseudotumor cerebri syndrome in children? Experience of a single tertiary clinic.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewIdiopathic intracranial hypertension (IIH), pseudotumor cerebri syndrome (PTCS), and benign intracranial hypertension are all terms that have been used for a neurologic syndrome consisting of elevated intracranial pressure (ICP), headache and vision loss without mass lesion or underlying infection or malignancy. In this review article, categorization, diagnostic criteria, symptom management strategies, and disease treatment options for pseudotumor cerebri syndrome will be discussed. RECENT
findingsThe Idiopathic Intracranial Hypertension Treatment Trial has now proven that acetazolamide should be the first line therapy in primary PTCS, but other treatment options exist in patients who cannot tolerate acetazolamide or in selected cases, which requires surgical intervention for PTCS which acutely threatens vision. Headache has also been shown to require focused treatment beyond therapies that lower ICP, specifically targeting coexistent primary headache disorders and medication overuse. Advances in treatment and diagnostic modalities have improved understanding of PTCS types and their treatment. The pathophysiology of primary PTCS, however, remains incompletely understood, but continued evaluation of cerebrospinal fluid flow dynamics, aquaporins, hormones, natriuretic peptides, and the link with female gender and obesity may lead to future answers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.